MLP Care (MPARK) Company Report

Healthcare for all

We initiate the coverage of MLP Care in our research scope with a target price of TL385.00 for a 12-month period, recommending a BUY with a potential return of 54%. i) Increasing healthcare expenditures domestically and evolving consumer habits, ii) Increasing health insurance demand stands out as the main themes of our valuation. We anticipate the high profitability observed in late 2023 to persist in 2024. Positioned as attractive in terms of current Market Cap, the company trades at a multiple of 10.0x P/E in our 2024E estimates and 7.2x P/E in our 2025E estimates.